A randomized, open-label, single-dose, four-cycle, bioequivalence trial of a completely repeated crossover design of single oral niergoline tablets in healthy adult subjects on an empty stomach and in a postprandial state

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: 4fc3f418ede47e6c83e050e11d4ca65f42dffe56
First added on: Apr 08, 2025